Smartphone app aims to boost cancer patient voice during treatment

NCT ID NCT04568278

Completed Symptom relief Sponsor: Samsung Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a mobile app helps cancer patients undergoing chemotherapy or radiation therapy report their symptoms more effectively. Over 200 participants used the app to track side effects for 8 weeks. The goal was to see if the app improves how patients recognize and communicate symptoms to their healthcare team.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: mobile application for symptom reporting
What this could lead to: If it works, this could help cancer patients better communicate their symptoms to doctors, potentially improving care.
What could go wrong: This is a completed study with 222 participants, but it focuses on reporting behavior, not direct health outcomes. The app may not change actual symptom management or quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer esophageal cancer female reproductive organ cancer head and neck cancer lung cancer neoplasm Patient Participation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEOPLASMS

Contacts and locations

Locations

Danbee Kang

Seoul, 135-710, South Korea
Samsung Medical Center

Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.